| Bombardier and Vista Sign Service Agreement Focused on Smart Parts Programs |
Globe Newswire |
04/20 |
05:00 |
| Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema |
Globe Newswire |
04/20 |
04:00 |
| Supplemental Update Regarding the Board’s Current Pricing Approach for Future M&A-Related Share Issuances |
Globe Newswire |
04/20 |
04:00 |
| Resilinc’s Agentic Factory for Operational Supply Chain Resilience at Hannover Messe 2026 |
Globe Newswire |
04/20 |
04:00 |
| Niu Technologies to Report First Quarter 2026 Financial Results on May 18, 2026 |
Globe Newswire |
04/20 |
04:00 |
| Plaee Expands Its Focus as Prediction Markets Gain Momentum |
Globe Newswire |
04/20 |
03:28 |
| Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology |
Globe Newswire |
04/20 |
02:30 |
| Swedish Goverment Holds Decision on Norra Karr Exploitation Concession; Directors Exercise Options Injecting New Capital; Investor Relations Engagement |
Globe Newswire |
04/20 |
02:30 |
| Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases |
Globe Newswire |
04/20 |
02:30 |
| Viral Vectors & Plasmid DNA Manufacturing Market Size Worth USD 29.82 Bn by 2035 Growing Demand for Gene and Cell Therapies Drives the Market |
Globe Newswire |
04/20 |
02:26 |
| Tencent Invests in Kaspi.kz Alongside Co-Founder & CEO Mikheil Lomtadze and Long-Term U.S. Institutional Investors |
Globe Newswire |
04/20 |
02:10 |
| Schneider Electric and Deloitte collaborate to drive AI-enabled digital transformation across industrial operations |
Globe Newswire |
04/20 |
02:00 |
| Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026 |
Globe Newswire |
04/20 |
01:30 |
| B2Gold Reports Update on Fire-Related Incident to the Crushing Circuit at the Goose Mine |
Globe Newswire |
04/19 |
23:45 |
| Douce Vallée Expands B2B Operations with Bespoke Corporate Gifting and Event Dessert Services in Hong Kong |
Globe Newswire |
04/19 |
23:37 |
| Duncan Brand Announces Release of “Mind the Gap,” Addressing Gaps in Leadership Development Practices |
Globe Newswire |
04/19 |
21:45 |
| SQRIL Expands to Africa with Launch of Stablecoin-to-Fiat QR Payments and Mobile Money Integration in Tanzania, Kenya, and South Africa |
Globe Newswire |
04/19 |
21:00 |
| BIGC Targets Global Live Market with Its All-in-One Digital Venue, Achieving 1,028% Growth in Three Years |
Globe Newswire |
04/19 |
20:58 |
| Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting |
Globe Newswire |
04/19 |
20:00 |
| Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 |
Globe Newswire |
04/19 |
19:45 |
| Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026 |
Globe Newswire |
04/19 |
19:00 |
| KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma |
Globe Newswire |
04/19 |
18:00 |
| Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting |
Globe Newswire |
04/19 |
18:00 |
| Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 |
Globe Newswire |
04/19 |
16:00 |
| Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting |
Globe Newswire |
04/19 |
14:00 |
